While meta-analyses may be well suited to overcome limitations in power of smaller sized phase II trials, extreme caution Cardiac
No takes yet. Share an insight, caveat, or question.
Aßmus et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: